Intercure Ltd. SEC filings INCR
Intercure Ltd. has 119 filings in SEC EDGAR's recent list, going back to Apr 21, 2021. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 8, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 6-K/A | Filing | Aug 27, 2026 | Aug 27, 2026 |
| 6-K | Current report (foreign issuer) | Aug 26, 2026 | Aug 26, 2026 |
| 4 | Insider transaction | Aug 24, 2026 | Jun 9, 2026 |
| 6-K | Current report (foreign issuer) | Aug 24, 2026 | Aug 24, 2026 |
| D | Filing | Aug 19, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 11, 2026 | Aug 11, 2026 |
| 6-K | Current report (foreign issuer) | Aug 4, 2026 | Aug 4, 2026 |
| 6-K/A | Filing | Jul 27, 2026 | Jul 27, 2026 |
| 6-K | Current report (foreign issuer) | Jul 22, 2026 | Jul 22, 2026 |
| 6-K | Current report (foreign issuer) | Jun 22, 2026 | Jun 22, 2026 |
| 6-K | Current report (foreign issuer) | Jun 15, 2026 | Jun 15, 2026 |
| 6-K | Current report (foreign issuer) | May 1, 2026 | Apr 30, 2026 |
| 20-F | Annual report (foreign issuer) | Apr 30, 2026 | Dec 31, 2025 |
| 3 | Initial insider ownership | Apr 20, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 20, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 20, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 16, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 16, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 16, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 3, 2026 | Mar 3, 2026 |
| 6-K | Current report (foreign issuer) | Feb 19, 2026 | Feb 19, 2026 |
| 6-K | Current report (foreign issuer) | Dec 30, 2025 | Dec 30, 2025 |
| 6-K | Current report (foreign issuer) | Dec 18, 2025 | Dec 18, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Dec 9, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 25, 2025 | Nov 25, 2025 |
| 6-K | Current report (foreign issuer) | Nov 3, 2025 | Nov 3, 2025 |
| 6-K | Current report (foreign issuer) | Oct 8, 2025 | Oct 8, 2025 |
| 6-K | Current report (foreign issuer) | Sep 19, 2025 | Sep 19, 2025 |
| UPLOAD | Letter from the SEC | Aug 29, 2025 | — |
| CORRESP | Letter to the SEC | Aug 7, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2025 | — |
| 6-K | Current report (foreign issuer) | May 1, 2025 | May 1, 2025 |
| 20-F | Annual report (foreign issuer) | May 1, 2025 | Dec 31, 2024 |
| NT 20-F | Filing | May 1, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Feb 13, 2025 | Feb 12, 2025 |
| 6-K | Current report (foreign issuer) | Feb 3, 2025 | Feb 3, 2025 |
| 6-K/A | Filing | Jan 31, 2025 | Jan 31, 2025 |
| 6-K | Current report (foreign issuer) | Jan 27, 2025 | Jan 27, 2025 |
| 6-K | Current report (foreign issuer) | Dec 30, 2024 | Dec 30, 2024 |
| 6-K | Current report (foreign issuer) | Dec 20, 2024 | Dec 20, 2024 |
| 6-K | Current report (foreign issuer) | Dec 20, 2024 | Dec 20, 2024 |
| 6-K | Current report (foreign issuer) | Nov 25, 2024 | Nov 25, 2024 |
| 6-K | Current report (foreign issuer) | Nov 4, 2024 | Nov 4, 2024 |
| 6-K | Current report (foreign issuer) | Oct 28, 2024 | Oct 28, 2024 |
| 6-K/A | Filing | Sep 17, 2024 | Sep 17, 2024 |
| 6-K | Current report (foreign issuer) | Sep 13, 2024 | Sep 13, 2024 |
| 6-K | Current report (foreign issuer) | Aug 29, 2024 | Aug 29, 2024 |
| 6-K | Current report (foreign issuer) | Aug 28, 2024 | Aug 28, 2024 |
| 6-K | Current report (foreign issuer) | May 21, 2024 | May 21, 2024 |
| 6-K | Current report (foreign issuer) | May 1, 2024 | Apr 30, 2024 |
| 20-F | Annual report (foreign issuer) | May 1, 2024 | Dec 31, 2023 |
| NT 20-F | Filing | May 1, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Apr 1, 2024 | Apr 1, 2024 |
| 6-K | Current report (foreign issuer) | Feb 13, 2024 | Feb 13, 2024 |
| 6-K | Current report (foreign issuer) | Feb 13, 2024 | Feb 13, 2024 |
| 6-K | Current report (foreign issuer) | Jan 31, 2024 | Jan 31, 2024 |
| 6-K | Current report (foreign issuer) | Dec 14, 2023 | Dec 14, 2023 |
| 6-K | Current report (foreign issuer) | Nov 8, 2023 | Nov 8, 2023 |
| 6-K | Current report (foreign issuer) | Oct 31, 2023 | Oct 31, 2023 |
| 6-K | Current report (foreign issuer) | Oct 17, 2023 | Oct 17, 2023 |
| 6-K | Current report (foreign issuer) | Aug 31, 2023 | Aug 31, 2023 |
| 6-K | Current report (foreign issuer) | Aug 14, 2023 | Aug 14, 2023 |
| 6-K | Current report (foreign issuer) | Jul 24, 2023 | Jul 24, 2023 |
| 6-K | Current report (foreign issuer) | Jul 11, 2023 | Jul 11, 2023 |
| 6-K | Current report (foreign issuer) | Jun 12, 2023 | Jun 12, 2023 |
| 6-K | Current report (foreign issuer) | May 16, 2023 | May 16, 2023 |
| 20-F | Annual report (foreign issuer) | May 1, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Apr 26, 2023 | Apr 26, 2023 |
| 6-K | Current report (foreign issuer) | Apr 25, 2023 | Apr 25, 2023 |
| 6-K | Current report (foreign issuer) | Apr 20, 2023 | Apr 20, 2023 |
| 6-K | Current report (foreign issuer) | Apr 3, 2023 | Apr 3, 2023 |
| 6-K | Current report (foreign issuer) | Apr 3, 2023 | Apr 3, 2023 |
| 6-K | Current report (foreign issuer) | Feb 14, 2023 | Feb 14, 2023 |
| 6-K | Current report (foreign issuer) | Feb 1, 2023 | Feb 1, 2023 |
| 6-K | Current report (foreign issuer) | Dec 19, 2022 | Dec 19, 2022 |
| 6-K | Current report (foreign issuer) | Dec 5, 2022 | Dec 5, 2022 |
| 6-K | Current report (foreign issuer) | Nov 23, 2022 | Nov 23, 2022 |
| 6-K | Current report (foreign issuer) | Nov 17, 2022 | Nov 17, 2022 |
| 6-K | Current report (foreign issuer) | Nov 16, 2022 | Nov 16, 2022 |
| 6-K | Current report (foreign issuer) | Aug 18, 2022 | Aug 18, 2022 |
| 6-K | Current report (foreign issuer) | Jul 15, 2022 | Jul 15, 2022 |
| EFFECT | Filing | Jun 24, 2022 | — |
| POS AM | Filing | Jun 23, 2022 | — |
| 6-K | Current report (foreign issuer) | May 24, 2022 | May 24, 2022 |
| SC 13G | Ownership over 5% (passive) | May 16, 2022 | — |
| 20-F | Annual report (foreign issuer) | Apr 28, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Apr 7, 2022 | Apr 7, 2022 |
| 6-K | Current report (foreign issuer) | Feb 9, 2022 | Feb 9, 2022 |
| 6-K | Current report (foreign issuer) | Jan 4, 2022 | Jan 4, 2022 |
| 6-K | Current report (foreign issuer) | Dec 3, 2021 | Dec 3, 2021 |
| 6-K | Current report (foreign issuer) | Dec 3, 2021 | Dec 3, 2021 |
| 6-K | Current report (foreign issuer) | Nov 17, 2021 | Nov 17, 2021 |
| 6-K | Current report (foreign issuer) | Oct 25, 2021 | Oct 25, 2021 |
| EFFECT | Filing | Oct 4, 2021 | — |
| 424B3 | Prospectus | Oct 4, 2021 | — |
| CORRESP | Letter to the SEC | Sep 30, 2021 | — |
| CORRESP | Letter to the SEC | Sep 23, 2021 | — |
| F-1/A | Filing | Sep 23, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2021 | — |
| F-1/A | Filing | Sep 9, 2021 | — |
| 6-K | Current report (foreign issuer) | Sep 1, 2021 | Sep 1, 2021 |
| SEC STAFF ACTION | Filing | Aug 31, 2021 | — |
| CERT | 20f cert | Aug 30, 2021 | — |
| CORRESP | Letter to the SEC | Aug 27, 2021 | — |
| 20FR12B/A | Filing | Aug 16, 2021 | — |
| F-1/A | Filing | Aug 3, 2021 | — |
| 20FR12B/A | Filing | Aug 3, 2021 | — |
| CORRESP | Letter to the SEC | Aug 2, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2021 | — |
| F-1 | Registration statement (foreign issuer) | Jul 15, 2021 | — |
| 20FR12B | Filing | Jul 14, 2021 | — |
| DRSLTR | Filing | Jul 2, 2021 | — |
| DRS/A | Filing | Jul 2, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2021 | — |
| DRSLTR | Filing | Jun 10, 2021 | — |
| DRS/A | Filing | Jun 10, 2021 | — |
| UPLOAD | Letter from the SEC | May 18, 2021 | — |
| DRS | Filing | Apr 21, 2021 | — |
Showing 119 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INCR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Herzliya, Israel
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1857030
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.